Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Most Favored Nation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
BIO Statement on Industry Tariffs
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
BIO Extends Agreement with Avantor for Five…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…
All Press Releases
  • Show All
Search
Results
Event Tags
January 24, 2018
BIO Congratulates Alex Azar on Confirmation asSecretary of Health and Human Services Washington, DC (January 24, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding…
January 18, 2018
First-of-its-kind report highlights the need to stimulate development efforts for depression therapeutics. Washington, DC (January 18, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of…
January 10, 2018
Washington, DC (January 10, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the review of the 340B drug pricing program released by the House Energy & Commerce Committee today:
January 9, 2018
“Biotechnology Sector is a Driver of the ‘Fourth Industrial Revolution’”Washington, D.C. (January 9, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new report from the Interagency Task Force on Agriculture and Rural…
January 2, 2018
Washington, DC (January 2, 2018) – “BIO joins the nation – and the great state of Utah – in applauding Senator Hatch for his many years of service, and for proving time and time again to be a strong champion for biomedical innovation."
December 21, 2017
Washington, DC (December 21, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act.  This bipartisan bill, sponsored…
December 14, 2017
U.S. Government and 16 like-minded WTO Members Call forImplementation of the Sanitary and Phytosanitary (SPS) AgreementWashington, D.C. (December 14, 2017) – The Biotechnology Innovation Organization (BIO) is applauding efforts by the United States…
December 14, 2017
The Biotechnology Innovation Organization (BIO) today announces preliminary programing for the upcoming BIO CEO & Investor Conference to be held February 12-13, 2018 in New York. The program will include a diverse group of industry luminaries at…
November 30, 2017
BIO is disappointed that EPA did not raise the Renewable Fuel Standard's advanced and cellulosic biofuel volumes for 2018 in line with the industry’s ability to produce them.
November 15, 2017
Washington, DC (November 15, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds Sens. Thom Tillis (R-NC) and Gary Peters (D-MI) for introducing the Fostering Innovation Act.  This vital legislation would build on the…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.